Assessing Treatment Outcomes Of ChemoImmunotherapy In EXTENSIVE-STAGE SMALL_CELL_LUNG_CÁNCER : An Integrated Clinical And Radiomics Approach .

Conclusions :

The Integrated Clinical And Radiomics Model Can Predict The Treatment Outcomes in Patients With ES-SCLC Receiving CHEMOIMMUNOTHERAPY, Rendering a Convenient And Low-Cost Prognostic Model For Decision-Making Regarding Patient Management . ...